Table 1: Here we present a series of 5 clinical cases of women who are representative of this tendency of delayed conception seen in industrialized countries.
|
Patient 1 |
Patient 2 |
Patient 3 |
Patient 4 |
Patient 5 |
Age (years) |
38 |
38 |
43 |
37 |
36 |
Toxic habits |
None |
None |
None |
None |
None |
Clinical background |
Adenoids and Apendicitis |
None |
None |
Endometriosis, Myomitosis |
Alpha-thalassemia |
Menarche (years) |
13 |
13 |
14 |
12 |
13 |
Menstrual formula |
3-4/35 |
5/28 |
Regular cycles of 28 |
5/28 |
7/28 |
BMI |
32 |
Normo-weight |
27.5 |
22.6 |
21.2 |
Previous gestations |
0 |
0 |
2 |
0 |
1 |
Time of subfertility |
8 months |
2 years |
5 years |
6 months |
7 months |
Other medication |
None |
None |
200 mg Iodine 400 mg Folic acid 2 mg Vitamin B1 Alternate months |
300 mg N-acetylcystein, 100 mg Alpha-lipoic acid, 12.5 mg Bromelin, 5 mg Zinc |
None |
Insulin Res |
- |
- |
- |
- |
- |
AMH (ng/ml) |
1.3 |
- |
0.7 |
- |
- |
FSH (mU/ml) |
5.8 |
- |
10.9 |
- |
14 |
LH (ng/ml) |
- |
- |
9.6 |
- |
26 |
Vitamin D (ng/ml) |
31.7 |
26 |
- |
- |
- |
Spermogram |
Normal |
- |
N/A |
N/A |
Normal |
BMI: Body Mass Index; FSH: Follicle-Stimulating Hormone; AMH: Anti-Mullerian Hormone; LH: Luteinizing Hormone